Seth Karol is an Oncology physician affiliated with St. Jude Children's Research Hospital. OpenAlex indexes 160 publications with 2,471 citations (h-index 25); ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
262 Danny Thomas Pl
Mail Stop 260
Memphis, TN 381053678
Telephone
901-595-3300Registry record last updated 2 May 2019.
Clinical trials
- Real World Asparaginase Therapy Toxicity
Sponsor: St. Jude Children's Research Hospital
- Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
Sponsor: St. Jude Children's Research Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment
- JAZZ PHARMACEUTICALS INC.Program year20252 payments
- SERVIER PHARMACEUTICALS LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2020–2024 per NIH RePORTER. The latest:
- Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic Leukemia
St. Jude Children'S Research Hospital
FY2024$224,070K08CA250418 - Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic Leukemia
St. Jude Children'S Research Hospital
FY2023$224,070K08CA250418 - Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic Leukemia
St. Jude Children'S Research Hospital
FY2022$225,570K08CA250418
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Molecular and pharmacological heterogeneity of ETV6::RUNX1 acute lymphoblastic leukemia
Nature Communications
2025 - Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations
JNCI Journal of the National Cancer Institute
2024 - Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia
Journal of Clinical Oncology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Jeffrey Towbin, MD
St. Jude Children's Research Hospital
Raul Ribeiro, MD
St. Jude Children's Research Hospital
Thomas Merchant, DO
St. Jude Children's Research Hospital
Alberto Pappo, MD
St. Jude Children's Research Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”